Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04862650
Title Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Marcelo Bonomi

oropharynx cancer

laryngeal squamous cell carcinoma

oral squamous cell carcinoma

head and neck squamous cell carcinoma

hypopharynx cancer


Carboplatin + Cemiplimab + Paclitaxel

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST